American Cannabis Company names new CEO and chairman

American Cannabis Company, Inc. reported a leadership change.

(High)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

American Cannabis Company, Inc. reported a leadership change. On May 8, Joe Cleghorn stepped down as Chief Executive Officer and moved into the role of Chairman of the Advisory Board, where he will continue providing strategic guidance and support to the leadership team.

The Board of Directors appointed James Woodend as the new Chief Executive Officer, effective immediately, and also named him Chairman of the Board of Directors. The company states there were no disagreements between Mr. Cleghorn and the company regarding operations, policies, or practices, and it highlights Mr. Woodend’s leadership and operational experience as important for its long-term objectives.

Insights

American Cannabis Company shifts CEO role while keeping prior leader involved.

The company replaced its Chief Executive Officer, with Joe Cleghorn stepping down and remaining as Chairman of the Advisory Board. This structure keeps institutional knowledge in place while allowing new executive leadership under James Woodend.

Woodend is also appointed Chairman of the Board, concentrating leadership and board oversight in a single individual. The company notes there were no disagreements with Cleghorn and emphasizes Woodend’s operational experience and strategic vision, framing the transition as supportive of long-term objectives.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Filing type: Form 8-K Effective date of CEO change: May 8, 2026

2 metrics

Filing type Form 8-K Leadership change disclosure

Effective date of CEO change May 8, 2026 Joe Cleghorn steps down; James Woodend appointed

Key Terms

Chief Executive Officer, Chairman of the Advisory Board, Chairman of the Board of Directors, Emerging growth company

4 terms

Chief Executive Officer financial

"Joe Cleghorn stepped down from his role as Chief Executive Officer of AMMJ"

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

Chairman of the Advisory Board financial

"Mr. Cleghorn will continue to serve the Company as Chairman of the Advisory Board"

Chairman of the Board of Directors financial

"Mr. Woodend was appointed Chairman of the Board of Directors"

Emerging growth company regulatory

"Emerging growth company [ ]"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did AMMJ announce in this Form 8-K?

American Cannabis Company announced that Joe Cleghorn stepped down as Chief Executive Officer. The Board appointed James Woodend as the new CEO and Chairman, marking a transition in top leadership roles for the company.

Will Joe Cleghorn remain involved with American Cannabis Company (AMMJ)?

Yes. Joe Cleghorn will continue to serve as Chairman of the Advisory Board. In that role, he is expected to provide strategic guidance and support to the company’s leadership team following his departure as Chief Executive Officer.

What new roles did James Woodend assume at American Cannabis Company (AMMJ)?

James Woodend was appointed Chief Executive Officer and Chairman of the Board of Directors. His appointment is effective immediately, and the company cites his leadership, operational experience, and strategic vision as important for long-term objectives.

Did Joe Cleghorn leave AMMJ because of disagreements with the company?

The company states there were no disagreements between Joe Cleghorn and American Cannabis Company. This includes matters related to operations, policies, or practices, suggesting an orderly leadership transition rather than a dispute-driven departure.

When did the CEO transition at American Cannabis Company (AMMJ) occur?

The transition occurred on May 8, 2026, when Joe Cleghorn stepped down as Chief Executive Officer. On the same date, the Board of Directors appointed James Woodend as the new CEO and Chairman of the Board of Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/11/2026 - 11:04 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 8, 2026

AMERICAN CANNABIS COMPANY, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

(State or other jurisdiction of incorporation or organization)

Commission File Number

000-26108

90-1116625

(I.R.S. Employer

Identification Number)

1004 S Tejon St Colorado Springs, CO 80903

(Address of Principal Executive Offices and Zip Code)

(303) 974-4770

(Issuer's telephone number)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbols	Name of Exchange on Which Registered
Common	AMMJ	None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.

On May 8, Joe Cleghorn stepped down from his role as Chief Executive Officer of AMMJ (the “Company”). Mr. Cleghorn will continue to serve the Company as Chairman of the Advisory Board, where he will provide strategic guidance and support to the Company’s leadership team. The Board of Directors appointed James Woodend as the Company’s new Chief Executive Officer, effective immediately. In addition, Mr. Woodend was appointed Chairman of the Board of Directors. The Company believes Mr. Woodend’s leadership, operational experience, and strategic vision will support the Company’s continued growth and long-term objectives. There were no disagreements between Mr. Cleghorn and the Company on any matter relating to the Company’s operations, policies, or practices.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMERICAN CANNABIS COMPANY, INC.

(Registrant)

By: /s/ James Woodend

Name: James Woodend

Date: May 11, 2026

Title: CEO

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

American Cannabis Company names new CEO and chairman

Rhea-AI Filing Summary

Positive

Negative